Fundraising
FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial
FineHeart Successfully Tests the Implantable, Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS Heart Pump
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation
Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist program in cancer immunotherapy
